Results 231 to 240 of about 983,526 (287)
Neurorights: comparing some perspectives on legal reform in global south to analyze the Brazilian case. [PDF]
Moreira A, Vilaça M.
europepmc +1 more source
Purpose To evaluate clinical outcomes and failure rates after arthroscopic capsular plication for multidirectional shoulder instability in patients with and without hypermobile Ehlers‐Danlos syndrome. Methods A retrospective case series with prospectively collected outcomes was conducted between 2015 and 2023 in patients undergoing arthroscopic ...
Chandler M. Catanzaro +6 more
wiley +1 more source
Managing courts in competitive authoritarian regimes: Co-optation, repression and resistance in Hungary. [PDF]
Hanelt E, Vincze A.
europepmc +1 more source
Purpose To evaluate cost, outcomes, and incremental cost‐effectiveness of arthroscopic partial meniscectomy comparing visualization using a 1.9 mm distal chip‐on‐tip needlescope versus a standard 4 mm glass rod lens arthroscope. Methods We retrospectively reviewed prospectively collected data (from a larger randomized controlled trial) on patients ...
James H. Lubowitz, Chad Lavender
wiley +1 more source
Alleged Misinterpretation of PET-CT in Esophageal Carcinoma Staging: A Medico-Legal Case Report. [PDF]
De Queiroz FR, Jordão NV, Machado DT.
europepmc +1 more source
From Interferon Signature to the Clinical Landscape: Type I Interferonopathies
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz +13 more
wiley +1 more source
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week, double‐blind, placebo‐controlled, phase 3 Program for Evaluation
Philip J. Mease +20 more
wiley +1 more source
Few rights, great threats, endless struggles: setbacks and resistance in the last decade of fights for legal abortion in Brazil. [PDF]
Cardoso NM +4 more
europepmc +1 more source

